Leading causes of fever in patients with liver function disorders
Abstract
The aim of review. Analysis of literature data on the possible causes of fever at patients with disorders of liver function. Article presents pathophysiological mechanisms of development of fever. The algorithm of assessment of patient with disorder of liver function and fever is submitted.
Original positions. Fever in patients with liver failure can be caused both by infectious and non-infectious causes. Infections are the most frequent causes of fever at disorder of the liver function, that accounts for immunodeficiency state at this category of patients. An important role in development of fever at patients with liver cirrhosis is bacterial overgrowth syndrome, bacterial translocation processes and, as a consequence, endotoxemia. If the site of infection is not detected, it is necessary to keep in mind the option of development of non-infectious fever within acute phase reaction, neoplastic process or reaction to applied pharmaceutical agents.
Conclusion. At development of fever at patients with liver failure carrying out differential diagnostics of the causes of body temperature elevation is necessary that allows more differentiated approaches to treatment.
About the Authors
V. T. Ivashkin
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
M. A. Morozova
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
M. V. Mayevskaya
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
References
1. Болезни печени и желчевыводящих путей: Руководство для врачей / Под ред. В.Т. Ивашкина. – М.: Изд. дом «М-Вести», 2002. – С. 84–85.
2. Буеверов А.О. Оксидативный стресс и его роль в повреждении печени // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2002. – Т. 12, № 4. – С. 21–25.
3. Буеверов А.О., Маевская М.В., Ивашкин В.Т. Алкогольная болезнь печени // Рус. мед. журн. – 2001. – Т. 9, № 2. – С. 61–64.
4. Ивашкин В.Т. Осложнения портальной гипертензии при циррозе печени // Рос. физиол. журн. им. И.М. Сеченова. – 2009. – Т. 95, № 10. – С. 1088.
5. Патологическая физиология: Учебник / Под ред. А.Д. Адо. – М.: Триада-Х, 2000. – С. 202.
6. Федосьина Е.А., Маевская М.В. Спонтанный бактериальный перитонит. Клиника, диагностика, лечение, профилактика // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2007. – Т. 17, № 2. – С. 4–9.
7. Akriviadis E., Botla R., Briggs W. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial // Gastroenterology. – 2000. – Vol. 119. – P. 1637–1648.
8. Allam N.A. Spontaneous bacterial empyema in liver cirrhosis: An underdiagnosed pleural complication // Saudi J. Gastroenterol. – 2008. – Vol. 14. – P.43–45.
9. Bellot P., Frances R., Such J. Bacterial translocation in cirrhosis // Gastroenterol. Hepatol. – 2008. – Vol. 31, N 8. – P. 508–514.
10. Campillo B., Dupeyron C., Richardet J.P. et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin // Clin. Infect. Dis. – 1998. – Vol. 26. – P.1066–1070.
11. Cirera I., Bauer T.M., Navasa M. et al. Bacterial translocation of enteric organisms in patients with cirrhosis // J. Hepatol. – 2001. – Vol. 34. – P. 32–37.
12. Cleary J.F. Fever and sweats: including the immunocompromised hosts. In: Berger A., Portenoy R.K., Weissman D.E., eds // Principles Pract. Support. Oncol. – Philadelphia, Pa: Lippicott-Raven Publishers, 1998. – P. 119–131.
13. Cruz R., Reis С., Tanajura D. et al. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms of urinary tract infection: a case series study // Braz. J. Infect. Dis. – 2006. – Vol. 10, N 6. – P. 126–135.
14. Dalal S., Zhukovsky S. Pathophysiology and management of fever // J. Support. Oncol. – 2006. – Vol. 4. – P. 9–16.
15. Dinarello C.A. Endogenous pyrogens: the role of cytokines in the pathogenesis of fever // Fever: basic mechanisms and management / Ed. P.A. Mackowiak. – N. J.: Raven Press, 1991. – P. 23–47.
16. Dinarello Ch. Review: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed // J. Endotoxin Res. – 2004. – Vol. 10, N 4. – P. 201– 222.
17. El-Naggar M.M., Khalil el-S.A., El-Daker M.A., Salama M.F.. Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites // J. Med. Microbiol. – 2008. – Vol. 57. – P. 1533–1538.
18. Fernandez J., Navasa M., Gomez J. et al. Bacterial infection in cirrhosis // Hepatology. – 2002. – Vol. 35. – P. 140–148.
19. Francйs R., Benlloch S., Zapater P. et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites // Hepatology. – 2004. – Vol. 39. – P. 484–491.
20. Francйs R., Muсoz C., Zapater P. et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites // Gut. – 2004. – Vol. 53. – P. 860–864.
21. Francйs R., Rodrнguez E., Muсoz C. et al. Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA // Eur. J. Gastroenterol. Hepatol. – 2005. – Vol. 17. – P. 45–51.
22. Fujimoto M., Uemura M., Nakatani Y. et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance // Alcohol. Clin. Exp. Res. – 2000. – Vol. 24. – P. 48–54.
23. Fukai H., Brauner B., Bode J.C., Bode C. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay // J. Hepatol. – 1991. – Vol. 12. – P.162–169.
24. Garcia-Tsao G. Bacterial infection in cirrhosis: treatment and prophylaxis // J. Hepatol. – 2005. – Vol. 42. – P. 585–592.
25. Garcia-Tsao G. Spontaneous bacterial peritonitis: a historical perspective // J. Hepatol. – 2004. – Vol. 41. – P. 522–527.
26. Garcia-Tsao G., Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis // Best Pract. Res. Clin. Gastroenterol. – 2004. – Vol. 18, N 2. – P. 353–372.
27. Giovanni T.L., Teghanemt A., Zhang D. et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation of picomolar concentrations // Proc. Natl. Acad. Sci. USA. – 2004. – Vol. 101. – P. 4186–4191.
28. Hanck Cl., Rossol S., Bцcker et al. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis // Alcohol Alcohol. – 1998. – Vol. 33, N 6. – P. 606–608.
29. Johnson Р. Pathophysiology of fever Part 1: The role of cytokines // Dimensions Crit. Care Nurs. – 1997. – Vol. 16, N 4. – P. 135–143.
30. Jun D.W., Kim K.T., Lee O.Y. et al. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients // Dig. Dis. Sci. – 2009. – Vol. 11. – P. 41–48.
31. Khoruts A., Stahnke L., McClain C.J. et al. Circulating tumor necrosis factor, interleukin-1 and interleukin6 concentrations in chronic alcoholic patients // Hepatology. – 1991. – Vol. 13. – P. 267–276.
32. Kuo Ch.-H., Changchien Chi-Sin, Chaur-Young Yang et al. Bacteremia in patients with cirrhosis of the liver // Liver. – 1999. – Vol. 11, N 6. – P. 334–339.
33. Lucey M.R., Mathurin Ph., Morgan T.R. Alcoholic hepatitis // N. Engl. J. Med. – 2009. – Vol. 360, N 26. – P. 2758–2769.
34. Mackowiak P.A. Drug fever // Fever: basic mechanisms and management / Ed. P.A. Mackowiak. – N. J.: Raven Press, 1991. – P. 255–265.
35. Mitsuzawa H., Nishitani C., Hyakushima N. et al. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice // J. Immunol. – 2006. – Vol. 177. – P. 8133–8139.
36. Modlin R.L., Brightbill H.D., Godowski P.J. The toll of innate immunity on microbial pathogens // N. Engl. J. Med. – 1999. – Vol. 340, N 23. – P. 1834–1835.
37. Morencos F.C., Castaсo G.H., Ramos L.M. et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis // Dig. Dis. Sci. – 1996. – Vol. 41, N 3. – P. 552–556.
38. Navasa M., Fernandez J., Rodes J. Bacterial infections in liver cirrhosis // Ital. J. Gastroenterol. Hepatol. – 1999. – Vol. 31. – P. 616–625.
39. Navasa M., Rimola A., Rodes J. Bacterial infections in liver disease // Semin. Liver Dis. – 1997. – Vol. 17, N 4. – P. 323–333.
40. Netea M.G., Kullberg B.J., Van der Meer J.W. Circulating cytokines as mediators of fever // Clin. Infect. Dis. – 2000. – Vol. 31 (suppl. 5). – P. 178–184.
41. O’Malley C.M., Frumento R.J., Mets B. et al. Endotoxemia during left ventricular assist device insertion relationship between risk factors and outcome // Br. J. Anaesth. – 2004. – Vol. 92. – P. 131–133.
42. Oksenberg R.D., Castelli T.A., Fica C.A. Infective endocarditis in patients with chronic hepatic failure: a four cases series // Rev. Chil. Infectol. – 2009. – Vol. 26, N 3. – P. 258–262.
43. Pande C., Kumar A., Sarin S.K. Small intestinal bacterial overgrowth in cirrhosis is related to severity of liver disease // Aliment. Pharmacol. Ther. – 2009. – Vol. 29, N 12. – P. 1273–1281.
44. Parlesak A., Schafer C., Schutz T. et al. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease // J. Hepatol. – 2000. – Vol. 32. – P. 742–747.
45. Rayo R.K., Seth A., Sheth P. Recent advances in alcoholic liver disease. Role of intestinal permeability and endotoxemia in alcoholic liver disease // Am. J. Physiol. Gastrointest. Liver Physiol. – 2004. – Vol. 286. – P. 881–884.
46. Rolando N., Harvey F., Brahm J. et al. Fungal infection: a common, unrecognised complication of acute liver failure // J. Hepatol. – 1991. – Vol. 12, N 1. – P. 9.
47. Rolando N., Harvey F., Brahm J. et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients // Hepatology. – 1990. – Vol. 11, N 1. – P. 49–53.
48. Rosa H., Silverio A.O., Perini R.F. et al. Bacterial infection in cirrhotic patients and its relationship with alcohol // Am. J. Gastroenterol. – 2000. – Vol. 95. – P. 1290–1293.
49. Saper C.B., Breder C.D. Endogenous pyrogens in the CNS: role in the febrile response // The human hypothalamus in health and disease / Eds. D.F. Swaab, M.A. Hofman, M. Mirmiran et al. // Prog. Brain Res. – 1992. – Vol. 93. – P. 419–429.
50. Scarborough D.E. Cytokine modulation of pituitary hormone secretion // Ann. N. Y. Acad. Sci. – 1990. – Vol. 594. – P. 169–187.
51. Simazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness. on Toll-like receptor 4 // J. Exp. Med. – 1999. – Vol. 189. – P. 1777–1782.
52. Singh V.V., Toskes P.P. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment // Curr. Treat Options. Gastroenterol – 2004. – Vol. 7. – P. 19–28.
53. Such J., Runyon B.A. Spontaneous bacterial peritonitis // Clin. Infect. Dis. – 1998. – Vol. 27. – P. 669–674.
54. Thieblemont N., Wright S.D. Transport of bacterial lipopolysaccharide to the golgi apparatus // J. Exp. Med. – 1999. – Vol. 190, N 4. – P. 523–534.
55. Wheeler M.D. Endotoxin and Kupffer cell activation in alcoholic liver disease // Alcohol Res. Health. – 2003. – Vol. 27, N 4. – P. 300–306.
56. Lee W.M. Acute liver failure // N. Engl. J. Med. – 1993. – Vol. 329, N 25. – P. 1862–1872.
Review
For citations:
Ivashkin V.T., Morozova M.A., Mayevskaya M.V. Leading causes of fever in patients with liver function disorders. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010;20(1):21-29. (In Russ.)
Views:
311
Email this article 
